PHA-793887
PHA-793887 is a small molecule inhibitor investigated in clinical trials for advanced or metastatic solid tumors. It has been utilized in preclinical research to study its effects on cell cycle progression and antitumor activity in both cellular and animal models.
Product Specifications
CAS Number
718630-59-2
Product Name Alternative
Inhibitor, inhibit, Apoptosis, CDK, CDK2/CyclinA, CDK2/CyclinE, CDK1/CyclinB, CDK7/CyclinH, CDK5/p25, Cyclin dependent kinase, PHA793887, PHA-793887, PHA 793887
Field of Research
Cell Biology, Metabolism Research
Purity
98.02% (May vary between batches)
Solubility
Ethanol:67 mg/mL (185.35 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:55 mg/mL (152.15 mM) ;10% DMSO+90% Saline:2.5 mg/mL (6.92 mM)
Smiles
CC (C) CC (=O) Nc1n[nH]c2c1CN (C (=O) C1CCN (C) CC1) C2 (C) C
Molecular Formula
C19H31N5O2
Molecular Weight
361.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2620592 100 µg
Liver FABP/FABP1 Rabbit Polyclonal Antibody (FITC)
Sign In for Pricing
View Details 
037986 200 µL
LRRTM1, ID (LRRTM1, Leucine-rich repeat transmembrane neuronal protein 1)
Sign In for Pricing
View Details